Transparency Market Research
Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018
Buy Now Request Sample
Published Date: June 2013
Single User License: US $ 4595 Multi User License: US $ 7595
115 Pages Report
Corporate User License: US $ 10595
REPORT DESCRIPTION Stem Cells Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2012 – 2018 Stem cells are undifferentiated cells which are capable of differentiating into any type of cell that make-up the human body and thus, are capable of producing non-regenerative cells such as neural and myocardial cells. This report estimates the market for global stem cells in terms of revenue (USD billion) for the period 2012 – 2018, keeping 2011 as the base year. The global stem cells market is mainly segmented into four major sub-types namely market by products, market by technology, market by applications and market by geography. The market by products is segmented into three sub-types, namely adult stem cells, human embryonic stem cells and other type of stem cells. Adult stem cells are further segmented into hematopoietic stem cells, mesenchymal stem cells, neuronal stem cells, dental stem cells and umbilical cord stem cells. The other types of stem cells include induced pluripotent stem cells, natural rosette cells and very small embryonic like stem cells. The global stem cells market by technology is segmented into four sub-types, namely cell acquisition, cell production, cryopreservation and expansion and sub-culture. Cell acquisition
Browse Report : Stem Cells Market
is further segmented into three sub-types, namely bone marrow harvest, apheresis and umbilical cord blood. Cell production is further segmented into therapeutic cloning, in vitro fertilization, isolation and cell culture. The global stem cells market by application is segmented into regenerative medicines and drug discovery and development. Regenerative medicines are further segmented into ten sub-types, namely neurological disorders, orthopedics, cancer, hematological disorders, cardiovascular diseases, injuries, diabetes, liver disorders, incontinence and other disorders like Crohn’s disease, infertility, immunodeficiency disorders and organ transplants. The global stem cells market is also segmented on the basis of geography into North America, Europe, Asia and rest of the world (RoW) regions and the market in terms of USD billion is provided in this report. The report highlights the market shares of key players in 2011. The company profiles for some of the key players, namely Advanced Cell Technology Inc., STEMCELL Technologies Inc., Cellular Engineering Technologies Inc., BioTime Inc., Aastrom Biosciences Inc. and California Stem Cell Inc. in terms of company overview, financial overview, business strategies, recent developments and product portfolio is also covered. The global stem cells market is categorized into the following segments:
Stem Cells Market by Products o
Adult Stem Cells
Hematopoietic Stem Cells
Mesenchymal Stem Cells
Neuronal Stem Cells
Dental Stem Cells
Umbilical Cord Stem Cells
o
Human Embryonic Stem Cells
o
Induced Pluripotent Stem Cells
o
Natural Rosette Cells
o
Very Small Embryonic Like Stem Cells
Stem Cells Market by Technology o
Cell Acquisition
o
Bone Marrow Harvest
Apheresis
Umbilical Blood Cord
Cell Production
Therapeutic Cloning
In Vitro Fertilization
Isolation
Cell Culture
o
Cryopreservation
o
Expansion and Sub-Culture
Stem Cells Market by Applications o
o
Regenerative Medicine
Neurological Disorders
Orthopedics
Cancer
Hematological disorders
Cardiovascular diseases
Injuries
Wound Care
Spinal Cord Injury
Others (Joint Injuries, Eye Injuries, Lacerations and Concussions)
Diabetes
Liver Disorder
Incontinence
Others (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder)
Drug Discovery and Development
Browse Report : http://www.transparencymarketresearch.com/stem-cellsmarket.html

Stem Cells Market by Geography o
North America
o
Europe
o
Asia
o
Rest of the World (RoW)
TABLE OF CONTENTS Chapter 1 Preface 1.1 Report Description 1.2 Research Methodology
Chapter 2 Executive Summary Chapter 3 Market Overview 3.1 Market Trends and Future Outlook 3.1.1 Global Stem Cells Market, 2010 – 2018 (USD Billion) 3.2 Market Dynamics 3.2.1 Market Drivers 3.2.1.1 Unmet Medical Needs 3.2.1.2 Increasing Government Support 3.2.1.3 Growing Medical Tourism 3.2.1.4 Rising Stem Cells Banking Services 3.2.1.5 Impact Analysis of the Market Drivers 3.2.2 Market Restraints
3.2.2.1 High Cost of Treatment 3.2.2.2 Government Regulations against Unethical Harvesting of Stem Cells 3.2.2.3 Impact Analysis of the Market Restraints 3.2.3 Market Opportunities 3.2.3.1 Rising Neurodegenerative Disease Patients 3.2.3.2 Increasing Disposable Income in Emerging Nations 3.2.3.3 Replacing Animal Tissue in Drug Discovery 3.2.3.4 Growing Contract Research Industry 3.2.4 Porter’s Five Forces Analysis for the Global Stem Cells Market 3.2.4.1 Bargaining Power of Suppliers 3.2.4.2 Bargaining Power of Buyers 3.2.4.3 Threat of New Entrants 3.2.4.4 Threat of Substitutes 3.2.5 Competitive Rivalry 3.3 Market Attractiveness 3.3.1 Market Attractiveness Analysis of the Global Stem Cells Market, By Geography
Chapter 4 Global Stem Cells Market, By Products 4.1 Market Segmentation: Global Stem Cells Market, By Products 4.2 Overview 4.3 Adult Stem Cells Market, 2010 – 2018 (USD Billion) 4.3.1 Hematopoietic Stem Cells Market, 2010 – 2018 (USD Billion) 4.3.2 Mesenchymal Stem Cells Market, 2010 – 2018 (USD Billion) 4.3.3 Neuronal Stem Cells Market, 2010 – 2018 (USD Billion) 4.3.4 Dental Stem Cells (Mesenchymal Stem Cells, Neuronal Stem Cells) Market, 2010 – 2018 (USD Billion) 4.3.5 Umbilical Cord Stem Cells (Hematopoietic Stem Cells, Mesenchymal Stem Cells) Market, 2010 – 2018 (USD Billion)
Browse Report : http://www.transparencymarketresearch.com/stem-cellsmarket.html
4.4 Human Embryonic Stem Cells Market, 2010 – 2018 (USD Billion) 4.5 Induced Pluripotent Stem Cells Market, 2010 – 2018 (USD Billion) 4.6 Rat Neural Stem Cells Market, 2010 – 2018 (USD Billion) 4.7 Very Small Embryonic-Like Stem Cells Market, 2010 – 2018 (USD Billion)
Chapter 5 Global Stem Cells Market, By Technology 5.1 Market Segmentation: Global Stem Cells Market, By Technology 5.2 Overview 5.3 Global Stem Cell Acquisition Market, 2010 – 2018 (USD Billion) 5.3.1 Global Bone Marrow Harvest for Stem Cells, 2010 – 2018 (USD Billion) 5.3.2 Global Apheresis for Stem Cells Market, 2010 – 2018 (USD Billion) 5.3.3 Global Umbilical Cord Blood Market, 2010 – 2018 (USD Billion) 5.4 Global Stem Cell Production Market, 2010 – 2018 (USD Billion) 5.4.1 Global Therapeutic Cloning for Stem Cells Market, 2010 – 2018 (USD Billion) 5.4.2 Global Stem Cells Production By In Vitro Fertilization Market, 2010 – 2018 (USD Billion) 5.4.3 Global Stem Cell Isolation Market, 2010 – 2018 (USD Billion) 5.4.4 Global Stem Cell Culture Market, 2010 – 2018 (USD Billion) 5.5 Global Stem Cell Cryopreservation Market, 2010 – 2018 (USD Billion) 5.6 Global Stem Cells Expansion and Sub-Culture Market, 2010 – 2018 (USD Billion)
Chapter 6 Global Stem Cells Market, By Application 6.1 Market Segmentation: Global Stem Cells Market, By Application 6.2 Overview 6.3 Global Stem Cells Market in Regenerative Medicine, 2010 – 2018 (USD Billion)
6.3.1 Stem Cells Market in Neurology, 2010 – 2018 (USD Billion) 6.3.2 Global Stem Cells Market in Orthopedics, 2010 – 2018 (USD Billion) 6.3.3 Global Stem Cells Market in Oncology, 2010 – 2018 (USD Billion) 6.3.4 Global Stem Cells Market in Hematology, 2010 – 2018 (USD Billion) 6.3.5 Global Stem Cells Market for Cardiovascular and Myocardial Infarction, 2010 – 2018 (USD Billion) 6.3.6 Global Stem Cells Market for Injuries, 2010 – 2018 (USD Billion) 6.3.6.1 Global Stem Cells Market for Wound Care, 2010 – 2018 (USD Billion) 6.3.6.2 Global Stem Cells Market for Spinal Cord Injuries, 2010 – 2018 (USD Billion) 6.3.6.3 Global Stem Cells Market for Other (Joint Injuries, Eye Injuries, Lacerations and Concussions) Injuries, 2010 – 2018 (USD Billion) 6.3.7 Global Stem Cells Market for Diabetes, 2010 – 2018 (USD Billion) 6.3.8 Global Stem Cells Market for Liver Disorders, 2010 – 2018 (USD Billion) 6.3.9 Global Stem Cells Market for Incontinence, 2010 – 2018 (USD Billion) 6.3.10 Global Stem Cells Market for Other (Crohn’s Disease, Infertility, Immunodeficiency Disorder, Organ Transplants, Ophthalmic Disorder) Regenerative Medicine Applications, 2010 – 2018 (USD Billion) 6.4 Global Stem Cells Market in Drug Discovery and Development, 2010 – 2018 (USD Billion)
Chapter 7 Global Stem Cells Market, By Geography 7.1 Overview 7.2 North America 7.2.1 North America Stem Cells Market, 2010–2018 (USD Billion) 7.3 Europe 7.3.1 Europe Stem Cells Market, 2010–2018 (USD Billion) 7.4 Asia 7.4.1 Asia Stem Cells Market, 2010–2018 (USD Billion) 7.5 Rest of the World (Row)
7.5.1 Row Stem Cells Market, 2010–2018 (USD Billion) Browse Report : http://www.transparencymarketresearch.com/stem-cellsmarket.html
Chapter 8 Competitive Landscape 8.1 Heat Map Analysis for the Key Market Players 8.1.1 Advanced Cell Technology Inc. 8.1.2 STEMCELL Technologies Inc. 8.1.3 Cellular Engineering Technologies Inc. 8.1.4 Biotime Inc. 8.1.5 Cellartis AB 8.2 Business Strategies for Success 8.2.1 Focus on Research and Development 8.2.2 Partnerships, Collaborations and Acquisitions
Chapter 9 Company Profiles 9.1 Advanced Cell Technology 9.1.1 Company Overview 9.1.2 Financial Overview 9.1.3 Business Strategies 9.1.4 Product Portfolio 9.1.5 Recent Developments 9.2 Angel Biotechnology 9.2.1 Company Overview 9.2.2 Financial Overview 9.2.3 Business Strategies 9.2.4 Product Portfolio
9.2.5 Recent Developments 9.3 Bioheart 9.3.1 Company Overview 9.3.2 Financial Overview 9.3.3 Product Portfolio 9.3.4 Business Strategies 9.3.5 Recent Developments 9.4 Brainstorm Cell Therapeutics 9.4.1 Company Overview 9.4.2 Financial Overview 9.4.3 Business Strategies 9.4.4 Product Portfolio 9.4.5 Recent Developments 9.5 California Stem Cell Inc. 9.5.1 Company Overview 9.5.2 Product Portfolio 9.5.3 Business Strategies 9.5.4 Recent Developments 9.6 Celgene Corporation Inc. 9.6.1 Company Overview 9.6.2 Financial Overview 9.6.3 Business Strategies 9.6.4 Product Portfolio 9.6.5 Recent Developments 9.7 Cellartis AB 9.7.1 Company Overview 9.7.2 Business Strategies
Browse Report : http://www.transparencymarketresearch.com/stem-cellsmarket.html
9.7.3 Product Portfolio 9.7.4 Recent Developments 9.8 Cellular Engineering Technologies 9.8.1 Company Overview 9.8.2 Business Strategies 9.8.3 Product Portfolio 9.8.4 Recent Developments 9.9 Cytori Therapeutics Inc. 9.9.1 Company Overview 9.9.2 Financial Overview 9.9.3 Product Portfolio 9.9.4 Business Strategies 9.9.5 Recent Developments 9.10 Biotime Inc. 9.10.1 Company Overview 9.10.2 Financial Overview 9.10.3 Product Portfolio 9.10.4 Business Strategies 9.10.5 Recent Developments 9.11 Osiris Therapeutics 9.11.1 Company Overview 9.11.2 Financial Overview 9.11.3 Product Portfolio 9.11.4 Business Strategies
9.11.5 Recent Developments 9.12 Stemcelltechnologies Inc. 9.12.1 Company Overview 9.12.2 Financial Overview 9.12.3 Business Strategies 9.12.4 Product Portfolio 9.12.5 Recent Developments
About Us: Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Contact: Transparency Market Research 90 State Street, Suite 700, Albany NY - 12207 United States Tel: +1-518-618-1030 USA - Canada Toll Free 866-552-3453 Email: sales@transparencymarketresearch.com Website: http://www.transparencymarketresearch.com/